Munir Pirmohamed

Munir Pirmohamed

University of Liverpool

H-index: 123

Europe-United Kingdom

About Munir Pirmohamed

Munir Pirmohamed, With an exceptional h-index of 123 and a recent h-index of 66 (since 2020), a distinguished researcher at University of Liverpool, specializes in the field of Clinical Pharmacology, Pharmacogenomics, drug safety, drug hypersensitivity, pharmacovigilance.

His recent articles reflect a diverse array of research interests and contributions to the field:

Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment

Navigating duplication in pharmacovigilance databases: a scoping review

CYP3A4* 22 and bleeding risk in ticagrelor users.

Pharmacogenomics in cardiovascular disease

Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?

Cancer pharmacogenomics

Preventing adverse drug reactions

Recording of suspected adverse drug reaction reporting in veterinary free‐text clinical narratives

Munir Pirmohamed Information

University

Position

___

Citations(all)

62534

Citations(since 2020)

23378

Cited By

48117

hIndex(all)

123

hIndex(since 2020)

66

i10Index(all)

556

i10Index(since 2020)

410

Email

University Profile Page

University of Liverpool

Google Scholar

View Google Scholar Profile

Munir Pirmohamed Skills & Research Interests

Clinical Pharmacology

Pharmacogenomics

drug safety

drug hypersensitivity

pharmacovigilance

Top articles of Munir Pirmohamed

Title

Journal

Author(s)

Publication Date

Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment

Magnus Ingelman‐Sundberg

Munir Pirmohamed

2024/2/11

Navigating duplication in pharmacovigilance databases: a scoping review

Ronald Kiguba

Gerald Isabirye

Julius Mayengo

Jonathan Owiny

Phil Tregunno

...

2024/4/1

CYP3A4* 22 and bleeding risk in ticagrelor users.

Basic & clinical pharmacology & toxicology

Innocent G Asiimwe

Munir Pirmohamed

2024

Pharmacogenomics in cardiovascular disease

Richard Myles Turner

Munir Pirmohamed

2024/1/1

Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?

Benjamin Cross

Richard M Turner

J Eunice Zhang

Munir Pirmohamed

2024/4

Cancer pharmacogenomics

Pathology

Munir Pirmohamed

2024/2/1

Preventing adverse drug reactions

Pathology

Munir Pirmohamed

2024/2/1

Recording of suspected adverse drug reaction reporting in veterinary free‐text clinical narratives

Journal of Small Animal Practice

H Davies

E Blackwell

IS Fins

PJM Noble

G Pinchbeck

...

2024/3/5

A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment

Toxicological sciences

Monday O Ogese

Adam Lister

Liam Farrell

Joshua Gardner

Laila Kafu

...

2024/1/1

Genetic Determinants of Thiazide‐Induced Hyperuricemia, Hyperglycemia, and Urinary Electrolyte Disturbances–A Genome‐Wide Evaluation of the UK Biobank

Clinical Pharmacology & Therapeutics

Innocent G Asiimwe

Lauren Walker

Reecha Sofat

Andrea L Jorgensen

Munir Pirmohamed

...

2024/2/29

Role of Transporters and Enzymes in Metabolism and Distribution of 4-Chlorokynurenine (AV-101)

Molecular pharmaceutics

Waseema Patel

Ravi G Shankar

Mark A Smith

H Ralph Snodgrass

Munir Pirmohamed

...

2024/1/23

Adverse drug reactions and hospital admissions: Large case‐control study of patients aged 65–100 years using linked English primary care and hospital data

Pharmacoepidemiology and Drug Safety

Tjeerd Pieter van Staa

Munir Pirmohamed

Anita Sharma

Darren M Ashcroft

Iain Buchan

2024/1

The status of drug evaluation in older adults in the United Kingdom: Bridging the representation gap

Journal of the American Geriatrics Society

Lauren E Walker

Munir Pirmohamed

2024/2/23

Stroke Pharmacogenetics

Lauren E Walker

Anna Stewart

Sir Munir Pirmohamed

James F Meschia

Frances Bartlett Kinne

2024/4/10

Glycolysis: An early marker for vancomycin‐specific T‐cell activation

Clinical & Experimental Allergy

Joshua Gardner

Sean Hammond

Rebecca Jensen

Andrew Gibson

Matthew S Krantz

...

2024/1

Patients with naproxen‐induced liver injury display T‐cell memory responses toward an oxidative (S)‐O‐desmethyl naproxen metabolite but not the acyl glucuronide

Allergy

Paul Thomson

Nik Fragkas

Laila M Kafu

Guruprasad P Aithal

M Isabel Lucena

...

2024/1

The implementation of pharmacogenetics in the United Kingdom

John H McDermott

Videha Sharma

Jessica Keen

William G Newman

Munir Pirmohamed

2023/6/13

A genome-wide association study of stable warfarin dose in sub-Saharan African patients

Warfarin anticoagulation in patients with cardiovascular disease in sub-Saharan Africa

Innocent G Asiimwe

Barry Jacobson

Catriona Waitt

Christine Sekaggya-Wiltshire

Claire Hutchinson

...

2021/8

Updates in SJS/TEN: collaboration, innovation, and community

Madeline E Marks

Ramya Krishna Botta

Riichiro Abe

Thomas M Beachkofsky

Isabelle Boothman

...

2023

Clinical Relevance of Drug–Drug Interactions With Antibiotics as Listed in a National Medication Formulary: Results From Two Large Population‐Based Case‐Control Studies in …

Clinical Pharmacology & Therapeutics

Tjeerd Pieter van Staa

Munir Pirmohamed

Anita Sharma

Iain Buchan

Darren M Ashcroft

2023/2

See List of Professors in Munir Pirmohamed University(University of Liverpool)

Co-Authors

H-index: 123
C Day

C Day

Newcastle University

H-index: 110
Teri E. Klein

Teri E. Klein

Stanford University

H-index: 101
Ann Daly

Ann Daly

Newcastle University

H-index: 89
Tjeerd van Staa

Tjeerd van Staa

Manchester University

H-index: 86
Julie A Johnson

Julie A Johnson

University of Florida

H-index: 57
Andrew Owen

Andrew Owen

University of Liverpool

academic-engine